Inventor
RENO JOHN M
US45 patents
⚠️ This page may combine multiple inventors who share the name “RENO JOHN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEORX CORP
37 patentsUS6663881B2Dec 16, 2003
Therapeutic inhibitor of vascular smooth muscle cells
NEORX CORP178 citations99
US6569441B2May 27, 2003
Therapeutic inhibitor of vascular smooth muscle cells
NEORX CORP213 citations99
US6491938B2Dec 10, 2002
Therapeutic inhibitor of vascular smooth muscle cells
NEORX CORP166 citations99
US6306421B1Oct 23, 2001
Therapeutic inhibitor of vascular smooth muscle cells
NEORX CORP227 citations99
US5733925AMar 31, 1998
Therapeutic inhibitor of vascular smooth muscle cells
NEORX CORP1,012 citations99
US6358989B1Mar 19, 2002
Therapeutic inhibitor of vascular smooth muscle cells
NEORX CORP135 citations98
US5981568ANov 9, 1999
Therapeutic inhibitor of vascular smooth muscle cells
NEORX CORP682 citations98
US5811447ASep 22, 1998
Therapeutic inhibitor of vascular smooth muscle cells
NEORX CORP402 citations98
US5608060AMar 4, 1997
Biotinidase-resistant biotin-DOTA conjugates
NEORX CORP100 citations98
US5106951AApr 21, 1992
Antibody conjugates
NEORX CORP133 citations98
US6015897AJan 18, 2000
Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota
NEORX CORP69 citations96
US5630996AMay 20, 1997
Two-step pretargeting methods using improved biotin-active agent conjugates
NEORX CORP51 citations96
US5283342AFeb 1, 1994
Biotinylated small molecules
NEORX CORP61 citations96
US5976535ANov 2, 1999
Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
NEORX CORP76 citations95
US5968477AOct 19, 1999
Radiolabeled annexin conjugates with hexose and a chelator
NEORX CORP38 citations95
US5217705AJun 8, 1993
Method of diagnosing blood clots using fibrin-binding proteins
NEORX CORP120 citations95
US5171563ADec 15, 1992
Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
NEORX CORP44 citations93
US6416738B1Jul 9, 2002
Pretargeting methods and compounds
NEORX CORP32 citations92
US6358710B1Mar 19, 2002
Humanized antibodies that bind to the antigen bound by antibody NR-LU-13
NEORX CORP59 citations92
US6075010AJun 13, 2000
Small molecular weight ligand-hexose containing clearing agents
NEORX CORP24 citations92
US6022966AFeb 8, 2000
Pretargeting methods and compounds
NEORX CORP28 citations92
US5985826ANov 16, 1999
Methods of using hepatic-directed compounds in pretargeting strategies
NEORX CORP33 citations92
US5955605ASep 21, 1999
Biotinidase resistant biotin-DOTA conjugates
NEORX CORP36 citations92
US5886143AMar 23, 1999
Hepatic-directed compounds and reagents for preparation thereof
NEORX CORP37 citations92
US5624896AApr 29, 1997
Clearing agents useful in pretargeting methods
NEORX CORP39 citations92
US5616690AApr 1, 1997
Hexose derivatized human serum albumin clearing agents
NEORX CORP28 citations92
US5578287ANov 26, 1996
Three-step pretargeting methods using improved biotin-active agent
NEORX CORP33 citations92
US5175257ADec 29, 1992
Radiolabeled proteins for diagnostic or therapeutic use
NEORX CORP29 citations92
US5112953AMay 12, 1992
Radiolabeled proteins for diagnostic or therapeutic use
NEORX CORP30 citations92
US6171577B1Jan 9, 2001
Radiolabeled annexins
NEORX CORP33 citations91
US4877868AOct 31, 1989
Radionuclide antibody coupling
NEORX CORP46 citations89
US6709652B2Mar 23, 2004
Pretargeting methods and compounds
NEORX CORP8 citations74
US6287536B1Sep 11, 2001
Two-step pretargeting methods using improved bidtin-active agent conjugates
NEORX CORP10 citations74
US6024937AFeb 15, 2000
Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
NEORX CORP11 citations74
US7115248B2Oct 3, 2006
Radiolabeled annexins
NEORX CORP5 citations63
US6358490B2Mar 19, 2002
Three-step pretargeting methods and compounds
NEORX CORP6 citations63
US5506342AApr 9, 1996
Stabilized antibody fragments
NEORX CORP3 citations59